In this episode of the NVIDIA AI Podcast, host Noah Kravitz interviews Max Jaderberg, Chief AI Officer, and Sergei Yakneen, Chief Technology Officer, of Isomorphic Labs at GTC25 in San Jose. Max and Sergei discuss their backgrounds and how they came to Isomorphic Labs, a company focused on reimagining drug discovery with an AI-first approach. They challenge traditional drug discovery assumptions by building generalizable AI models, like AlphaFold, that can be applied across the entire proteome and chemical space, rather than focusing on single-disease solutions. They aim to create models as reliable as experiments, enabling faster and bolder drug design. They also discuss biology as an information processing system, the importance of infrastructure and compute, data strategies, and the future of AI in drug discovery, envisioning a world of precision and preventative medicine.
